Biomarker-Driven Radiation Therapy Dose Reduction After Transoral Robotic Surgery for the Treatment of HPV-Positive Oropharyngeal Cancer

计划入组 33 人 · 首次发布于 2022 年 5 月 24 日

HPV-associated Oropharyngeal Carcinoma (HPV-OPC)

计划入组 35 人 · 首次发布于 2026 年 7 月 22 日

BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients

计划入组 20 人 · 首次发布于 2022 年 5 月 6 日

Sig-HELP-E7SH-kdel

SOS1 / KRAS (KRAS -driven cancer)

Human papillomavirus tumor antigen vaccine (Vanderbilt University/Ingram Cancer Center)

CENTER WEST CANCER

United States

Fujian Cancer Hospital (Fujian Cancer Institute, Fujian Cancer Prevention and Treatment Center)

China

Shaw Regional Cancer Center

United States

HPV cfDNA Demonstrates 95% Sensitivity for Detecting HPV-Driven Oropharyngeal Cancer and Predicts Recurrence Months Before Imaging

Naveris Showcases NavDx Test Advances for HPV-Associated Oropharyngeal Cancer Surveillance at ASTRO 2024

Standard Chemoradiation Shows Superior Outcomes in HPV-Associated Oropharyngeal Cancer